상세 보기
Acalabrutinib vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Results at similar to 4 Years of Follow-up
- Welslau, Manfred;
- Jurczak, Wojciech;
- Pluta, Andrzej;
- Wach, Malgorzata;
- Lysak, Daniel;
- ... Lee, Jae Hoon;
- 외 13명
Citations
WEB OF SCIENCE
0- 제목
- Acalabrutinib vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Results at similar to 4 Years of Follow-up
- 저자
- Welslau, Manfred; Jurczak, Wojciech; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Simkovic, Martin; Kryachok, Irina; Illes, Arpad; De la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric; Lee, Jae Hoon; Usenko, Ganna; Wang, Min Hui; Yu, Ting; Ghia, Paolo
- 발행일
- 2022-11
- 유형
- Meeting Abstract
- 권
- 45
- 호
- SUPPL 3
- 페이지
- 170 ~ 170